The emerging potential of by-products as platforms for drug delivery systems

Current Drug Targets

Volumn 15, Issue 5, 2014, Pages 478-485

  Joanitti, Graziella A ^a,b   Silva, Luciano P ^a,b  

^a EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Agricultural byproducts; Biocompatibility; Biodegradability; Byproducts; Drug delivery systems; Nanobiotechnol ogy; Nanoparticle; Sustainability

Indexed keywords

AGAR; AGRO INDUSTRIAL BYPRODUCT; BAGASSE; BETA GLUCAN; CARRAGEENAN; CELLULOSE; CHITIN; CHITOSAN; COLLAGEN; DRUG CARRIER; GELATIN; INSULIN DETEMIR; KERATIN; LIPOPOLYSACCHARIDE; MELITTIN; NANOPARTICLE; NATURAL PRODUCT; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOAVAILABILITY; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; BIORESORBABILITY; COST; DRUG DELIVERY SYSTEM; DRUG RELEASE; MEMBRANE TRANSPORT; MICROORGANISM; NANOBIOTECHNOLOGY; NANOENCAPSULATION; NANOMEDICINE; NONHUMAN; PLANT; PREVENTION AND CONTROL; PURIFICATION; SUSTAINABILITY;

AGRICULTURE; ANIMALS; BIOTECHNOLOGY; CONSERVATION OF NATURAL RESOURCES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; INDUSTRIAL WASTE; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84898658870     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113149990171     Document Type: Article

References (63)

1. st ed. New York: Springer 2010.
2. st ed. New York: Wiley & Sons 2010.
3. st ed. Washington: American Chemical Society Symposium Series 1997.
4. Shamsi IH, Hussain N, Jiang L. Agro-industrial by-products utilization in animal nutrition. In: Technological Innovations in Major World Oil Crops; Gupta SK, New York: Springer 2012; Vol. 2: pp 209-20.
5. Magnan N, Larson DM, Taylor JE. Stuck on stubble? The non-market value of agricultural byproducts for diversified farmers in Morocco. Am J Agr Econ 2012; 94: 1055-1069.
6. Rouilly A, Rigal L. Agro-materials: a bibliographic review. J Mac-romol Sci C 2002; 42: 441-479.
7. Strobel G, Daisy B. Bioprospecting for microbial endophytes and their natural products. Microbial Mol Biol Rev 2003; 67: 491-502.
8. Makkar RS, Cameotra SS, Banat IM. Advances in utilization of renewable substrates for biosurfactant production. AMB Express 2011; 1: 5.
9. González-Hidalgo I, Bañón S, Ros JM. Evaluation of table olive by-product as a source of natural antioxidants. Int J Food Sci Tech 2012; 47: 674-681.
10. Kumar U. Agricultural products and by-products as a low cost adsorbent for heavy metal removal from water and wastewater: A review. Scientific Res Essay 2006; 1: 33-37.
11. Schieber A, Stintzing FC, Carle R. Byproducts of plant food processing as a source of functional compounds - recent developments. Trends Food Sci Technol 2001; 12: 401-413.
12. Gavrilescua M, Chisti Y. Biotechnology-a sustainable alternative for chemical industry. Biotechnol Adv 2005; 23: 471-499.
13. Patel PD, Dand N, Hirlekar RS, Kadam VJ. Drug Loaded Erythro-cytes: As Novel Drug Delivery System. Curr Pharm Des 2008; 14: 63-70.
14. Dasha M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan-A versatile semi-synthetic polymer in biomedical applications. Progr Polym Sci 2011; 36: 981-1014.
15. Elsadek B, Kratz F. Impact of albumin on drug delivery - New applications on the horizon. J Controlled Release 2012; 157: 4-28.
16. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J of Pharm 2009; 366: 170-184.
17. Demain AL. Pharmaceutically active secondary metabolites of microorganisms. Appl Microbiol Biotechnol 1999; 52: 455-463.
18. Lahaye M. Chemistry and physico-chemistry of phycocolloids. Cah Biol Mar 2001; 42: 137-157.
19. Soto ER, Cara AC, Kut LC, Castle MK, Ostroff GR. Glucan particles for macrophage targeted delivery of nanoparticles. J Drug Delivery 2012; 2012: 1-19.
20. Piazza M, Colombo M, Zanoni I, et al. Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling. Angew Chem Int Ed 2011; 50: 622-626.
21. Reddy N, Yang Y. Biofibers from agricultural byproducts for industrial applications. Trends Biotech 2005; 23: 22-27.
22. Pandey JK, Nakagaito AN, Takagi H. Fabrication and applications of cellulose nanoparticle-based polymer composites. Polymer Eng Sci 2013; 53: 1-8.
23. Tang LR, Huang B, Dai DS, Ou W, Un YP, Chen XR. Preparation and spectrum properties of cellulose nanoparticles. Spectrosc and Spect Anal 2010; 30: 1876-1879.
24. Purkait BS, Ray D, Sengupta S, Kar T, Mohanty A, Misra M. Isolation of cellulose nanoparticles from sesame husk. Ind Eng Chem Res 2011; 50: 871-876.
25. Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Eryth-rocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 2011; 108: 10980-10985.
26. Martin JJ, Cardamone JM, Irwin PL, Brown EM. Keratin capped silver nanoparticles - Synthesis and characterization of a nanomate-rial with desirable handling properties. Colloids Surf B 2011; 88: 354-361.
27. Papi M, Palmieri V, Maulucci G, et al. Controlled self assembly of collagen nanoparticle. J Nano Res 2011; 13: 6141-6147.
28. Lee EJ, Khan SA, Lim KH. Gelatin nanoparticle preparation by nanoprecipitation. J Biomat Sci-Polym E 2011; 22: 753-771.
29. Wang JJ, Zeng ZW, Xiao RZ, Xie TA, Zhou GL, Zhan XR, Wang SL. Recent advances of chitosan nanoparticles as drug carriers. Intl J Nanomed 2011; 6: 765-774.
30. Pan H, Soman NR, Schlesinger PH, Lanza GM, Wickline SA. Cytolytic peptide nanoparticles ("nanobees") for cancer therapy. WIREs Nanomed Nanobiotechnol 2011; 3: 318-327.
31. Becerril HA, Woolley AT. DNA-templated nanofabrication. Chem Soc Rev 2009; 38: 329-337.
32. Min B, Lim J, Ko S, Lee KG, Lee SH, Lee S. Environmentally friendly preparation of pectins from agricultural byproducts and their structural/rheological characterization. Bioresource Tech 2011; 102: 3855-3860.
33. Dazzi A, Prater CB, Hu QC, Chase DB, Rabolt JF, Marcott C. AFM-IR: Combining atomic force microscopy and infrared spec-troscopy for nanoscale chemical characterization. Appl Spectrosc 2012; 66: 1365-1384.
34. Bellan LM, Wu D, Langer RS. Current trends in nanobiosensor technology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011; 3: 229-246.
35. Mainardes RM, Silva LP. Drug delivery systems: past, present, and future. Curr Drug Targets 2004; 5(5): 449-455.
36. Bamrungsap S, Zhao ZL, Chen T, Wang L, Li CM, Fu T, tan WH. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine 2012; 7: 1253-1271.
37. Biagiotti S, Paoletti MF, Fraternale A, Rossi L, Magnani M. Drug Delivery by Red Blood Cells. IUBMB Life 2011; 63: 621-631.
38. Rathbone MJ, Hadgraft J, Roberts MS, Lane ME. Modified-Release Drug Delivery Technology, 2nd ed. New York: Informa Healthcare 2008.
39. Wang AZ, Langer R, Farokhzad OC. Nanoparticle Delivery of Cancer Drugs. Annu Rev Med 2012; 63: 185-198.
40. Grabnar PA, Kristl J. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers. J Microencap-sul 2011; 28: 323-335.
41. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004; 21: 387-422.
42. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Bio-interfaces 2010; 75: 1-18.
43. Sionkowska A. Current research on the blends of natural and synthetic polymers as new biomaterials: Review. Progr Polym Sci 2011; 36: 1254-76.
44. Materials Characterization Paper In Support of the Proposed Rule- making: Identification of Nonhazardous Secondary Materials That Are Solid Waste, 2010. Available from: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-RCRA-2008-0329-0243.
45. Casettari L, Vllasaliu D, Castagnino E, Stolnik S, Howdle S, Illum L. PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications. Progr Polym Sci 2012; 37: 659-685.
46. Oak Ridge National Laboratory. Economical recovery of byproducts in the mining industry. Engineering Science and Technology Division, Nuclear Science and Technology Division and Environmental Sciences Division at Oak Ridge National Laboratory, U.S. Department of Energy, 2001. Available from: http://www.lesdole.com/TM225.pdf
47. Visvanathan C, Vigneswaran S, Jegatheesan V. Industrial Waste Minimization. In: Encyclopedia of Life Support Systems (EOLSS) 2003. Available from: http://www.eolss.net/Sample-Chapters/C07/E2-14-02-00.pdf
48. UK House of Lords Science and Technology Committee 2010, 1st Report of Session 2009-2010.
49. Bundesinstitut für Risikobewertung. 2008. Available from: http://www.bfr.bund.de/cm/350/wahrnehmung_der_nanotechnologi e_in_der_bevoelkerung.pdf
50. Mihranyan A, Ferraz N, Strømme M. Current status and future prospects of nanotechnology in cosmetics. Prog Mater Sci 2012; 57: 875-910.
51. Fadeel B. Clear and present danger? Engineered nanoparticles and the immune system. Swiss Med Wkly 2012; 142: w3609.
52. Chatelet C, Damour O, Domard A. Influence of the degree of ace-tylation on some biological properties of chitosan films. Biomateri-als 2001; 22: 261-268.
53. Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 2012; 159: 14-26.
54. Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, Wang SL. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 2011; 6: 765-774.
55. Hamidi M, Zarrin A, Foroozesh M, Mohammadi-Samani S. Applications of carrier erythrocytes in delivery of biopharmaceuticals. J Control Release 2007; 118: 145-160.
56. Magnani M, Rossi L, Fraternale A, Bianchi M, Antonelli A, Crinelli R, Chiarantini L. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Ther 2002; 9: 749-751.
57. Beija M, Salvayre R, Lauth-de Viguerie N, Marty JD. Colloidal systems for drug delivery: from design to therapy. Trends Biotech-nol 2012; 30: 485-496.
58. Muzykantov VR. Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin Drug Deliv 2010; 7: 403-427.
59. Garcia-Fuentes M, Alonso MJ. Chitosan-based drug nanocarriers: where do we stand? J Control Release 2012; 161: 496-504.
60. Patel MP, Patel RR, Patel JK. Chitosan mediated targeted drug delivery system: a review. J Pharm Pharm Sci 2010; 13: 536-557.
61. Tanabe T, Okitsu N, Tachibana A, Yamauchi K. Preparation and characterization of keratin-chitosan composite film. Biomaterials 2002; 23: 817-825.
62. Benatti U, Giovine M, Damonte G, et al. Azidothymidine homod-inucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine. Biochem Biophys Res Commun 1996; 220: 20-25.
63. Senel S, McClure SJ. Potential applications of chitosan in veterinary medicine. Adv Drug Deliv Rev 2004; 56: 1467-1480.